{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T13:20:33Z","timestamp":1762521633042,"version":"3.40.3"},"reference-count":45,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2013,12,20]],"date-time":"2013-12-20T00:00:00Z","timestamp":1387497600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2013,12,20]],"date-time":"2013-12-20T00:00:00Z","timestamp":1387497600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Arch Virol"],"published-print":{"date-parts":[[2014,6]]},"DOI":"10.1007\/s00705-013-1954-6","type":"journal-article","created":{"date-parts":[[2013,12,20]],"date-time":"2013-12-20T18:20:54Z","timestamp":1387563654000},"page":"1359-1364","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Adjuvant effect of CD40 on H5N1 DNA vaccine in mice"],"prefix":"10.1007","volume":"159","author":[{"given":"Qin","family":"Chen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guangjian","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Renjie","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Junpeng","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guimei","family":"He","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2013,12,20]]},"reference":[{"key":"1954_CR1","doi-asserted-by":"publisher","first-page":"1374","DOI":"10.1056\/NEJMra052211","volume":"353","author":"JH Beigel","year":"2005","unstructured":"Beigel JH, Farrar J, Han A, Hayden F, Hyer R, De Jong M, Lochindarat S, Nguyen T, Nguyen T, Tran T (2005) Avian influenza A (H5N1) infection in humans. N Engl J Med 353:1374","journal-title":"N Engl J Med"},{"key":"1954_CR2","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1126\/science.279.5349.393","volume":"279","author":"K Subbarao","year":"1998","unstructured":"Subbarao K, Klimov A, Katz J, Regnery H, Lim W, Hall H, Perdue M, Swayne D, Bender C, Huang J (1998) Characterization of an avian influenza A (H5N1) virus isolated from a child with a fatal respiratory illness. Science 279:393\u2013396","journal-title":"Science"},{"key":"1954_CR3","unstructured":"Organization WH (2013) Cumulative number of confirmed human cases of avian influenza A (H5N1) reported to WHO, 2003\u20132013. World Health Organization, Geneva, Switzerland. http:\/\/www.who.int\/influenza\/human_animal_interface\/EN_GIP_20131008CumulativeNumberH5N1cases.pdf"},{"key":"1954_CR4","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1056\/NEJMoa044021","volume":"352","author":"K Ungchusak","year":"2005","unstructured":"Ungchusak K, Auewarakul P, Dowell SF, Kitphati R, Auwanit W, Puthavathana P, Uiprasertkul M, Boonnak K, Pittayawonganon C, Cox NJ (2005) Probable person-to-person transmission of avian influenza A (H5N1). N Engl J Med 352:333\u2013340","journal-title":"N Engl J Med"},{"key":"1954_CR5","doi-asserted-by":"publisher","first-page":"B40","DOI":"10.1016\/S0264-410X(02)00509-1","volume":"20","author":"J Wood","year":"2002","unstructured":"Wood J (2002) Selection of influenza vaccine strains and developing pandemic vaccines. Vaccine 20:B40\u2013B44","journal-title":"Vaccine"},{"key":"1954_CR6","doi-asserted-by":"publisher","first-page":"506","DOI":"10.1016\/j.molmed.2006.09.003","volume":"12","author":"T Horimoto","year":"2006","unstructured":"Horimoto T, Kawaoka Y (2006) Strategies for developing vaccines against H5N1 influenza A viruses. Trends Mol Med 12:506\u2013514","journal-title":"Trends Mol Med"},{"key":"1954_CR7","doi-asserted-by":"publisher","first-page":"1202","DOI":"10.1038\/nbt.2439","volume":"30","author":"S-S Wong","year":"2012","unstructured":"Wong S-S, Webby RJ (2012) An mRNA vaccine for influenza. Nat Biotechnol 30:1202\u20131204","journal-title":"Nat Biotechnol"},{"key":"1954_CR8","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1016\/S0024-3205(96)00502-4","volume":"60","author":"JJ Donnelly","year":"1996","unstructured":"Donnelly JJ, Ulmer JB, Liu MA (1996) DNA vaccines. Life Sci 60:163\u2013172","journal-title":"Life Sci"},{"key":"1954_CR9","doi-asserted-by":"crossref","first-page":"3635","DOI":"10.4049\/jimmunol.158.8.3635","volume":"158","author":"DM Klinman","year":"1997","unstructured":"Klinman DM, Yamshchikov G, Ishigatsubo Y (1997) Contribution of CpG motifs to the immunogenicity of DNA vaccines. J Immunol 158:3635\u20133639","journal-title":"J Immunol"},{"issue":"8","key":"1954_CR10","doi-asserted-by":"publisher","first-page":"796","DOI":"10.3201\/eid0805.010476","volume":"8","author":"SL Epstein","year":"2002","unstructured":"Epstein SL, Tumpey TM, Misplon JA, Lo C-Y, Cooper LA, Subbarao K, Renshaw M, Sambhara S, Katz JM (2002) DNA vaccine expressing conserved influenza virus proteins protective against H5N1 challenge infection in mice. Emerg Infect Dis 8(8):796\u2013801","journal-title":"Emerg Infect Dis"},{"key":"1954_CR11","doi-asserted-by":"publisher","first-page":"e2517","DOI":"10.1371\/journal.pone.0002517","volume":"3","author":"DJ Laddy","year":"2008","unstructured":"Laddy DJ, Yan J, Kutzler M, Kobasa D, Kobinger GP, Khan AS, Greenhouse J, Sardesai NY, Draghia-Akli R, Weiner DB (2008) Heterosubtypic protection against pathogenic human and avian influenza viruses via in vivo electroporation of synthetic consensus DNA antigens. PloS one 3:e2517","journal-title":"PloS one"},{"key":"1954_CR12","doi-asserted-by":"publisher","first-page":"6512","DOI":"10.1016\/j.vaccine.2009.08.053","volume":"27","author":"GE Price","year":"2009","unstructured":"Price GE, Soboleski MR, Lo C-Y, Misplon JA, Pappas C, Houser KV, Tumpey TM, Epstein SL (2009) Vaccination focusing immunity on conserved antigens protects mice and ferrets against virulent H1N1 and H5N1 influenza A viruses. Vaccine 27:6512\u20136521","journal-title":"Vaccine"},{"key":"1954_CR13","doi-asserted-by":"publisher","first-page":"2565","DOI":"10.1016\/j.vaccine.2010.01.029","volume":"28","author":"LR Smith","year":"2010","unstructured":"Smith LR, Wloch MK, Ye M, Reyes LR, Boutsaboualoy S, Dunne CE, Chaplin JA, Rusalov D, Rolland AP, Fisher CL (2010) Phase 1 clinical trials of the safety and immunogenicity of adjuvanted plasmid DNA vaccines encoding influenza A virus H5 hemagglutinin. Vaccine 28:2565\u20132572","journal-title":"Vaccine"},{"key":"1954_CR14","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1586\/erv.11.188","volume":"11","author":"F Saade","year":"2012","unstructured":"Saade F, Petrovsky N (2012) Technologies for enhanced efficacy of DNA vaccines. Expert Rev Vaccines 11:189\u2013209","journal-title":"Expert Rev Vaccines"},{"key":"1954_CR15","doi-asserted-by":"publisher","first-page":"pe25","DOI":"10.1126\/stke.2372004pe25","volume":"2004","author":"MM Harnett","year":"2004","unstructured":"Harnett MM (2004) CD40: a growing cytoplasmic tale. Sci Signal 2004:pe25","journal-title":"Sci Signal"},{"key":"1954_CR16","doi-asserted-by":"publisher","first-page":"272","DOI":"10.1097\/00062752-200307000-00004","volume":"10","author":"B O\u2019Sullivan","year":"2003","unstructured":"O\u2019Sullivan B, Thomas R (2003) Recent advances on the role of CD40 and dendritic cells in immunity and tolerance. Curr Opin Hematol 10:272\u2013278","journal-title":"Curr Opin Hematol"},{"key":"1954_CR17","doi-asserted-by":"publisher","first-page":"3477","DOI":"10.1016\/j.vaccine.2004.12.025","volume":"23","author":"TA Barr","year":"2005","unstructured":"Barr TA, Carlring J, Heath AW (2005) CD40 antibody as a potent immunological adjuvant: CD40 antibody provides the CD40 signal to B cells, but does not substitute for T cell help in responses to TD antigens. Vaccine 23:3477\u20133482","journal-title":"Vaccine"},{"key":"1954_CR18","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1046\/j.1365-2567.2003.01634.x","volume":"109","author":"TA Barr","year":"2003","unstructured":"Barr TA, Mccormick AL, Carlring J, Heath AW (2003) A potent adjuvant effect of CD40 antibody attached to antigen. Immunology 109:87\u201392","journal-title":"Immunology"},{"key":"1954_CR19","doi-asserted-by":"publisher","first-page":"958","DOI":"10.1128\/CVI.00080-06","volume":"13","author":"SL Gares","year":"2006","unstructured":"Gares SL, Fischer KP, Congly SE, Lacoste S, Addison WR, Tyrrell DL, Gutfreund KS (2006) Immunotargeting with CD154 (CD40 ligand) enhances DNA vaccine responses in ducks. Clin Vaccine Immunol 13:958\u2013965","journal-title":"Clin Vaccine Immunol"},{"key":"1954_CR20","doi-asserted-by":"publisher","first-page":"4062","DOI":"10.1016\/j.vaccine.2008.05.018","volume":"26","author":"J Liu","year":"2008","unstructured":"Liu J, Yu Q, Stone GW, Yue FY, Ngai N, Jones RB, Kornbluth RS, Ostrowski MA (2008) CD40L expressed from the canarypox vector, ALVAC, can boost immunogenicity of HIV-1 canarypox vaccine in mice and enhance the in vitro expansion of viral specific CD8+ T cell memory responses from HIV-1-infected and HIV-1-uninfected individuals. Vaccine 26:4062\u20134072","journal-title":"Vaccine"},{"key":"1954_CR21","doi-asserted-by":"publisher","first-page":"8147","DOI":"10.1016\/j.vaccine.2010.09.081","volume":"28","author":"Q Yao","year":"2010","unstructured":"Yao Q, Fischer KP, Li L, Agrawal B, Berhane Y, Tyrrell DL, Gutfreund KS, Pasick J (2010) Immunogenicity and protective efficacy of a DNA vaccine encoding a chimeric protein of avian influenza hemagglutinin subtype H5 fused to CD154 (CD40L) in Pekin ducks. Vaccine 28:8147\u20138156","journal-title":"Vaccine"},{"key":"1954_CR22","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1002\/jgm.1412","volume":"12","author":"H Xu","year":"2010","unstructured":"Xu H, Zhao G, Huang X, Ding Z, Wang J, Wang X, Cheng Y, Kang Y, Wang B (2010) CD40-expressing plasmid induces anti-CD40 antibody and enhances immune responses to DNA vaccination. J Gene Med 12:97\u2013106","journal-title":"J Gene Med"},{"key":"1954_CR23","volume-title":"Molecular cloning: a laboratory manual","author":"T Maniatis","year":"1982","unstructured":"Maniatis T, Fritsch EF, Sambrook J (1982) Molecular cloning: a laboratory manual. Cold Spring Harbor Laboratory, Cold Spring Harbor"},{"key":"1954_CR24","doi-asserted-by":"crossref","first-page":"11082","DOI":"10.2144\/97226bm15","volume":"22","author":"AR Gelsthorpe","year":"1997","unstructured":"Gelsthorpe AR, Gelsthorpe K, Sokol RJ (1997) Rapid isolation of total RNA from small samples of hypocelluar dense connective tissues. Biotechniques 22:11082\u201311086","journal-title":"Biotechniques"},{"key":"1954_CR25","doi-asserted-by":"publisher","first-page":"394","DOI":"10.1006\/abio.1993.1346","volume":"212","author":"I Feliciello","year":"1993","unstructured":"Feliciello I, Chinali G (1993) A modified alkaline lysis method for the preparation of highly purified plasmid DNA from Escherichia Coli. Anal Biochem 212:394\u2013401","journal-title":"Anal Biochem"},{"key":"1954_CR26","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1128\/JCM.37.4.937-943.1999","volume":"37","author":"T Rowe","year":"1999","unstructured":"Rowe T, Abernathy RA, Hu-Primmer J, Thompson WW, Lu X, Lim W, Fukuda K, Cox NJ, Katz JM (1999) Detection of antibody to avian influenza A (H5N1) virus in human serum by using a combination of serologic assays. J Clin Microbiol 37:937\u2013943","journal-title":"J Clin Microbiol"},{"key":"1954_CR27","doi-asserted-by":"publisher","first-page":"386","DOI":"10.1006\/meth.2001.1261","volume":"25","author":"A Giulietti","year":"2001","unstructured":"Giulietti A, Overbergh L, Valckx D, Decallonne B, Bouillon R, Mathieu C (2001) An overview of real-time quantitative PCR: applications to quantify cytokine gene expression. Methods 25:386\u2013401","journal-title":"Methods"},{"key":"1954_CR28","doi-asserted-by":"publisher","first-page":"8156","DOI":"10.1073\/pnas.0402443101","volume":"101","author":"Y Guan","year":"2004","unstructured":"Guan Y, Poon L, Cheung C, Ellis T, Lim W, Lipatov A, Chan K, Sturm-Ramirez K, Cheung C, Leung Y (2004) H5N1 influenza: a protean pandemic threat. Proc Nat Acad Sci USA 101:8156\u20138161","journal-title":"Proc Nat Acad Sci USA"},{"key":"1954_CR29","doi-asserted-by":"publisher","first-page":"13538","DOI":"10.1073\/pnas.0806901105","volume":"105","author":"M-W Chen","year":"2008","unstructured":"Chen M-W, Cheng T-JR, Huang Y, Jan J-T, Ma S-H, Alice LY, Wong C-H, Ho DD (2008) A consensus\u2013hemagglutinin-based DNA vaccine that protects mice against divergent H5N1 influenza viruses. Proc Nat Acad Sci 105:13538\u201313543","journal-title":"Proc Nat Acad Sci"},{"key":"1954_CR30","doi-asserted-by":"publisher","first-page":"2647","DOI":"10.1016\/S0264-410X(00)00495-3","volume":"19","author":"J-PY Scheerlinck","year":"2001","unstructured":"Scheerlinck J-PY (2001) Genetic adjuvants for DNA vaccines. Vaccine 19:2647\u20132656","journal-title":"Vaccine"},{"key":"1954_CR31","first-page":"69","volume":"73","author":"T Kawabe","year":"2011","unstructured":"Kawabe T, Matsushima M, Hashimoto N, Imaizumi K, Hasegawa Y (2011) CD40\/CD40 ligand interactions in immune responses and pulmonary immunity. Nagoya J Med Sci 73:69\u201378","journal-title":"Nagoya J Med Sci"},{"key":"1954_CR32","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1007\/978-3-540-92165-3_10","volume-title":"DNA vaccines against influenza viruses. Vaccines for pandemic influenza","author":"JH Kim","year":"2009","unstructured":"Kim JH, Jacob J (2009) DNA vaccines against influenza viruses. Vaccines for pandemic influenza. Springer, New York, pp 197\u2013210"},{"key":"1954_CR33","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1016\/j.coi.2004.02.002","volume":"16","author":"J Kang","year":"2004","unstructured":"Kang J, Der SD (2004) Cytokine functions in the formative stages of a lymphocyte\u2019s life. Curr Opin Immunol 16:180\u2013190","journal-title":"Curr Opin Immunol"},{"key":"1954_CR34","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1097\/00001432-200106000-00006","volume":"14","author":"M Heydtmann","year":"2001","unstructured":"Heydtmann M, Shields P, McCaughan G, Adams D (2001) Cytokines and chemokines in the immune response to hepatitis C infection. Curr Opin Infect Dis 14:279\u2013287","journal-title":"Curr Opin Infect Dis"},{"key":"1954_CR35","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1111\/j.1699-0463.1995.tb01092.x","volume":"103","author":"F Belardelli","year":"1995","unstructured":"Belardelli F (1995) Role of interferons and other cytokines in the regulation of the immune response. APMIS 103:161\u2013179","journal-title":"APMIS"},{"key":"1954_CR36","doi-asserted-by":"publisher","first-page":"10147","DOI":"10.1128\/JVI.79.16.10147-10154.2005","volume":"79","author":"DC Lee","year":"2005","unstructured":"Lee DC, Cheung C-Y, Law AH, Mok CK, Peiris M, Lau AS (2005) p38 mitogen-activated protein kinase-dependent hyperinduction of tumor necrosis factor alpha expression in response to avian influenza virus H5N1. J Virol 79:10147\u201310154","journal-title":"J Virol"},{"key":"1954_CR37","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1002\/1096-9071(200103)63:3<242::AID-JMV1007>3.0.CO;2-N","volume":"63","author":"K-F To","year":"2001","unstructured":"To K-F, Chan PK, Chan K-F, Lee W-K, Lam W-Y, Wong K-F, Tang NL, Tsang DN, Sung RY, Buckley TA (2001) Pathology of fatal human infection associated with avian influenza A H5N1 virus. J Med Virol 63:242\u2013246","journal-title":"J Med Virol"},{"key":"1954_CR38","doi-asserted-by":"publisher","first-page":"1567","DOI":"10.1084\/jem.178.5.1567","volume":"178","author":"TM Foy","year":"1993","unstructured":"Foy TM, Shepherd D, Durie F, Aruffo A, Ledbetter J, Noelle R (1993) In vivo CD40-gp39 interactions are essential for thymus-dependent humoral immunity. II. Prolonged suppression of the humoral immune response by an antibody to the ligand for CD40, gp39. J Exp Med 178:1567\u20131575","journal-title":"J Exp Med"},{"key":"1954_CR39","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1016\/1074-7613(94)90095-7","volume":"1","author":"T Kawabe","year":"1994","unstructured":"Kawabe T, Naka T, Yoshida K, Tanaka T, Fujiwara H, Suematsu S, Yoshida N, Kishimoto T, Kikutani H (1994) The immune responses in CD40-deficient mice: impaired immunoglobulin class switching and germinal center formation. Immunity 1:167\u2013178","journal-title":"Immunity"},{"key":"1954_CR40","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1111\/j.1600-065X.2009.00782.x","volume":"229","author":"R Elgueta","year":"2009","unstructured":"Elgueta R, Benson MJ, De Vries VC, Wasiuk A, Guo Y, Noelle RJ (2009) Molecular mechanism and function of CD40\/CD40L engagement in the immune system. Immunol Rev 229:152\u2013172","journal-title":"Immunol Rev"},{"key":"1954_CR41","doi-asserted-by":"publisher","first-page":"617","DOI":"10.1038\/378617a0","volume":"378","author":"IS Grewal","year":"1995","unstructured":"Grewal IS, Xu J, Flavell RA (1995) Impairment of antigen-specific T-cell priming in mice lacking CD40 ligand. Nature 378:617\u2013620","journal-title":"Nature"},{"key":"1954_CR42","doi-asserted-by":"crossref","first-page":"2025","DOI":"10.4049\/jimmunol.145.7.2025","volume":"145","author":"P Hodgkin","year":"1990","unstructured":"Hodgkin P, Yamashita L, Coffman R, Kehry M (1990) Separation of events mediating B cell proliferation and Ig production by using T cell membranes and lymphokines. J Immunol 145:2025\u20132034","journal-title":"J Immunol"},{"key":"1954_CR43","doi-asserted-by":"crossref","first-page":"3696","DOI":"10.4049\/jimmunol.147.11.3696","volume":"147","author":"PD Hodgkin","year":"1991","unstructured":"Hodgkin PD, Yamashita LC, Seymour B, Coffman RL, Kehry M (1991) Membranes from both Th1 and Th2 T cell clones stimulate B cell proliferation and prepare B cells for lymphokine-induced differentiation to secrete Ig. J Immunol 147:3696\u20133702","journal-title":"J Immunol"},{"key":"1954_CR44","doi-asserted-by":"publisher","first-page":"747","DOI":"10.1084\/jem.184.2.747","volume":"184","author":"M Cella","year":"1996","unstructured":"Cella M, Scheidegger D, Palmer-Lehmann K, Lane P, Lanzavecchia A, Alber G (1996) Ligation of CD40 on dendritic cells triggers production of high levels of interleukin-12 and enhances T cell stimulatory capacity: TT help via APC activation. J Exp Med 184:747\u2013752","journal-title":"J Exp Med"},{"key":"1954_CR45","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1016\/S1074-7613(00)80435-5","volume":"4","author":"M Kamanaka","year":"1996","unstructured":"Kamanaka M, Yu P, Yasui T, Yoshida K, Kawabe T, Horii T, Kishimoto T, Kikutani H (1996) Protective role of CD40 in Leishmania major infection at two distinct phases of cell-mediated immunity. Immunity 4:275\u2013281","journal-title":"Immunity"}],"container-title":["Archives of Virology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00705-013-1954-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00705-013-1954-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00705-013-1954-6","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00705-013-1954-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,8]],"date-time":"2025-04-08T22:01:25Z","timestamp":1744149685000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00705-013-1954-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,12,20]]},"references-count":45,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2014,6]]}},"alternative-id":["1954"],"URL":"https:\/\/doi.org\/10.1007\/s00705-013-1954-6","relation":{},"ISSN":["0304-8608","1432-8798"],"issn-type":[{"type":"print","value":"0304-8608"},{"type":"electronic","value":"1432-8798"}],"subject":[],"published":{"date-parts":[[2013,12,20]]},"assertion":[{"value":"11 September 2013","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 November 2013","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 December 2013","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}